Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Nanobac Pharmaceuticals, Inc. Announces Confirming Results

February 23rd, 2004

Nanobac Pharmaceuticals, Inc. Announces Confirming Results

Abstract:
Nanobac Pharmaceuticals, Inc. is pleased to announce the publication of independent research which confirms and validates Dr.'s Kajander and Ciftcioglu's findings of the living organism, Nanobacteria Sanguineum, as a causal agent in the formation of kidney stones.

Source:
Businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books



NNN
The Hunger Project